Diego Ingrosso Selected Research

Uremia

5/2019	Uremic Toxin Lanthionine Interferes with the Transsulfuration Pathway, Angiogenetic Signaling and Increases Intracellular Calcium.
4/2018	Zebrafish, a Novel Model System to Study Uremic Toxins: The Case for the Sulfur Amino Acid Lanthionine.
10/2017	The Sulfur Metabolite Lanthionine: Evidence for a Role as a Novel Uremic Toxin.
7/2016	Divergent behavior of hydrogen sulfide pools and of the sulfur metabolite lanthionine, a novel uremic toxin, in dialysis patients.
9/2012	Therapy of hyperhomocysteinemia in hemodialysis patients: effects of folates and N-acetylcysteine.
1/2012	Hyperhomocysteinemia in chronic renal failure: alternative therapeutic strategies.
1/2012	Homocysteinylated albumin promotes increased monocyte-endothelial cell adhesion and up-regulation of MCP1, Hsp60 and ADAM17.
1/2011	Hydrogen sulfide, a toxic gas with cardiovascular properties in uremia: how harmful is it?
9/2009	Epigenetics in hyperhomocysteinemic states. A special focus on uremia.
7/2009	Hyperhomocysteinemia in uremia--a red flag in a disrupted circuit.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diego Ingrosso Research Topics

Disease

17	Uremia 05/2019 - 03/2003
15	Hyperhomocysteinemia 10/2021 - 03/2003
9	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 03/2003
8	Chronic Renal Insufficiency 06/2021 - 09/2009
5	Inflammation (Inflammations) 01/2019 - 09/2009
4	Hepatocellular Carcinoma (Hepatoma) 05/2019 - 12/2011
4	Atherosclerosis 01/2016 - 12/2009
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2013 - 01/2004
4	Hypertension (High Blood Pressure) 01/2011 - 12/2009
2	Myocardial Infarction 01/2013 - 01/2011
2	Renal Insufficiency (Renal Failure) 01/2004 - 07/2003
1	Vascular Calcification 06/2021
1	COVID-19 01/2020
1	Cardiac Arrhythmias (Arrythmia) 04/2018
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 11/2017
1	Primary Hyperparathyroidism 11/2017
1	Pleural Effusion (Pleural Effusions) 01/2015
1	Neoplasms (Cancer) 01/2015
1	Malignant Mesothelioma 01/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2014
1	Secondary Hyperparathyroidism 01/2013
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2012
1	Epilepsy (Aura) 06/2012
1	Vascular Remodeling 01/2012
1	Stable Angina 10/2011
1	Acute Coronary Syndrome 10/2011
1	Stomach Ulcer (Gastric Ulcer) 01/2011
1	Parkinson Disease (Parkinson's Disease) 01/2010
1	Premature Aging 10/2007
1	Down Syndrome (Down's Syndrome) 10/2007
1	Homocysteinemia 05/2005
1	Fibrosis (Cirrhosis) 05/2005
1	Melanoma (Melanoma, Malignant) 04/2005
1	Fatigue 10/2004
1	Hemolysis 04/2002
1	Glucosephosphate Dehydrogenase Deficiency 04/2002

Drug/Important Bio-Agent (IBA)

20	HomocysteineIBA 10/2021 - 03/2003
16	Proteins (Proteins, Gene)FDA Link 10/2021 - 04/2002
6	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2019 - 01/2011
6	Folic Acid (Vitamin M)FDA LinkGeneric 05/2013 - 09/2004
6	DNA (Deoxyribonucleic Acid)IBA 09/2009 - 01/2004
5	lanthionineIBA 06/2021 - 07/2016
5	MethyltransferasesIBA 05/2019 - 05/2003
4	MicroRNAs (MicroRNA)IBA 05/2019 - 12/2011
4	Blood Proteins (Serum Proteins)IBA 01/2007 - 07/2003
3	CytokinesIBA 06/2021 - 01/2012
3	Vasodilator Agents (Vasodilators)IBA 01/2019 - 12/2009
3	ChemokinesIBA 02/2014 - 01/2012
2	Amino Acids FDA Link 10/2021 - 01/2012
2	Uremic ToxinsIBA 01/2019 - 07/2003
2	EnzymesIBA 04/2018 - 12/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2017 - 02/2014
2	Sulfur Amino AcidsIBA 10/2017 - 01/2004
2	AlbuminsIBA 01/2012 - 01/2006
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 07/2009 - 05/2005
2	Aspartic Acid (Aspartate)FDA Link 10/2004 - 04/2002
1	SulfurIBA 10/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020
1	Biological ProductsIBA 01/2019
1	Fibroblast Growth Factor-23IBA 11/2017
1	DisintegrinsIBA 11/2017
1	Metalloproteases (Metalloproteinases)IBA 11/2017
1	Sulfur Compounds (Compounds, Sulfur)IBA 10/2017
1	LyasesIBA 07/2016
1	CystathionineIBA 07/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 02/2014
1	efalizumab (Raptiva)FDA Link 02/2014
1	Etanercept (Enbrel)FDA Link 02/2014
1	Adalimumab (Humira)FDA Link 02/2014
1	Peptide Hydrolases (Proteases)FDA Link 07/2013
1	MineralsIBA 01/2013
1	Acetylcysteine (Siran)FDA LinkGeneric 09/2012
1	Methionine (L-Methionine)FDA Link 08/2012
1	Anticonvulsants (Antiepileptic Drugs)IBA 06/2012
1	HydrogenIBA 02/2012
1	N 30IBA 10/2011
1	C-Reactive ProteinIBA 10/2011
1	GasotransmittersIBA 01/2011
1	Levodopa (L Dopa)FDA LinkGeneric 01/2010
1	Cysteine (L-Cysteine)FDA Link 12/2009
1	propionylcarnitineIBA 01/2007
1	RNA (Ribonucleic Acid)IBA 05/2005
1	AntioxidantsIBA 04/2005
1	CosmeticsIBA 04/2005
1	Thiobarbituric Acid Reactive SubstancesIBA 04/2005
1	Olive OilIBA 04/2005
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 04/2005
1	AsparagineIBA 10/2004
1	Toxic ActionsIBA 07/2003
1	Oxidants (Oxidizing Agents)IBA 04/2002
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2002
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 04/2002

Therapy/Procedure

12	Renal Dialysis (Hemodialysis) 01/2020 - 07/2003
3	Therapeutics 05/2013 - 01/2012
1	Parathyroidectomy 01/2013
1	Kidney Transplantation 01/2013
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 07/2003